These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21480382)

  • 1. A case of late-life onset mania during Varenicline assisted smoking cessation.
    Francois D; Odom A; Kotbi N
    Int J Geriatr Psychiatry; 2011 Jun; 26(6):658-9. PubMed ID: 21480382
    [No Abstract]   [Full Text] [Related]  

  • 2. Varenicline induced mania in a 51 year old patient without history of bipolar illness.
    Hussain S; Kayne E; Guwanardane N; Petrides G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1162-3. PubMed ID: 21396974
    [No Abstract]   [Full Text] [Related]  

  • 3. Varenicline induces manic relapse in bipolar disorder.
    Knibbs N; Tsoi DT
    Gen Hosp Psychiatry; 2011; 33(6):641.e1-2. PubMed ID: 21749843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline (champix)-associated manic relapse in bipolar affective disorder.
    MacSuibhne S; Giwa TA; McCauley MD
    Ir Med J; 2010 Oct; 103(9):286. PubMed ID: 21186758
    [No Abstract]   [Full Text] [Related]  

  • 5. A manic episode in a 64-year-old man: an adverse effect of varenicline.
    Ahmed AI
    Gen Hosp Psychiatry; 2011; 33(2):200.e9-200.e11. PubMed ID: 21596218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline (Chantix) warnings: risk versus benefit.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):53. PubMed ID: 18617873
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S
    Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
    O'Malley SS
    Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436
    [No Abstract]   [Full Text] [Related]  

  • 9. A second varenicline trial.
    O'Brien CP
    Curr Psychiatry Rep; 2007 Oct; 9(5):346-7. PubMed ID: 17915071
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In brief: Cardiovascular safety of varenicline (Chantix).
    Med Lett Drugs Ther; 2011 Aug; 53(1371):65. PubMed ID: 21860367
    [No Abstract]   [Full Text] [Related]  

  • 12. The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.
    Kistler CE; Goldstein AO
    Nicotine Tob Res; 2012 Dec; 14(12):1391-3. PubMed ID: 22422928
    [No Abstract]   [Full Text] [Related]  

  • 13. Varenicline-induced manic episode in a patient with bipolar disorder.
    Kohen I; Kremen N
    Am J Psychiatry; 2007 Aug; 164(8):1269-70. PubMed ID: 17671294
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of recurrent depression as a result of treatment with varenicline.
    Popkin MK
    Am J Psychiatry; 2008 Jun; 165(6):774. PubMed ID: 18519539
    [No Abstract]   [Full Text] [Related]  

  • 16. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis caused by varenicline.
    Duparc A; Gosset P; Caron J; Lasek A; Modiano P
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1111-2. PubMed ID: 19175479
    [No Abstract]   [Full Text] [Related]  

  • 18. Varenicline and bupropion: suicide.
    Prescrire Int; 2012 Oct; 21(131):240. PubMed ID: 23189376
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline for tobacco dependence.
    Cantrell MA; Geraets D
    N Engl J Med; 2009 Feb; 360(7):730-1. PubMed ID: 19213691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.